Patterns of disease progression to checkpoint inhibitor immunotherapy in patients with stage IV non-small cell lung cancer.

Naomi Fei,Christina Attia,Mohammed Almubarak,Patrick C. Ma,Malcolm D. Mattes

Patterns of disease progression to checkpoint inhibitor immunotherapy in patients with stage IV non-small cell lung cancer.

2020

Naomi Fei
Christina Attia
Mohammed Almubarak
Patrick C. Ma
Malcolm D. Mattes

e21674Background: The purpose of this study was to assess patterns of disease progression for patients with metastatic non-small cell lung cancer (NSCLC) on checkpoint inhibitor immunotherapy in or...

Keywords:

Oncology
Stage IV non-small cell lung cancer
in patient
disease progression
Pathology
Immunotherapy
immune checkpoint inhibitors
Internal medicine
Medicine

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations